ArticlePathologica2022

Immunohistochemical assessment of cannabinoid type-1 receptor (CB1R) and its correlation with clinicopathological parameters in glioma.

Nader Choucair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.